Pharmacotherapy in a Multidisciplinary Paediatric Hospital: Polypharmacy and Drug–Drug Interaction Risk Illustrated with a Clinical Case

Pharmacotherapy in a Multidisciplinary Paediatric Hospital: Polypharmacy and Drug–Drug Interaction Risk Illustrated with a Clinical Case

Nowadays, the problems caused by polypharmacy are recognised and widely discussed in the medical community. Multimorbidity, which is not uncommon in paediatric practice, comes with an increase in the number of prescriptions and necessitates an active search for tools to reduce the potential risk and...

Full description

Bibliographic Details
Main Authors:	M. N. Kostyleva, A. B. Strok, S. S. Postnikov, A. N. Gratsianskaya, A. E. Ermilin
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-10-01
Series:	Безопасность и риск фармакотерапии
Subjects:	polypharmacy multimorbidity children glomerulonephritis therapeutic drug monitoring immuno-suppressants cyclosporine rifampicin drug interaction
Online Access:	https://www.risksafety.ru/jour/article/view/283

Similar Items

The evolution of polypharmacy: appropriate and problematic polypharmacy, choosing the right strategy and tactics
by: M. V. Leonova
Published: (2021-10-01)

Polypharmacy in the Management of Arterial Hypertension—Friend or Foe?
by: Camelia Cristina Diaconu, et al.
Published: (2021-11-01)

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College
by: Akshay Khandeparkar, et al.
Published: (2017-01-01)

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials
by: Salvatore Crisafulli, et al.
Published: (2021-10-01)

Polypharmacy: definition, impact on outcomes, need for correction
by: S. Yu. Martsevich, et al.
Published: (2023-07-01)

Polypharmacy and potential drug–drug interactions in patients with rheumatoid arthritis
by: Zakaria M Al-Ghazaly, et al.
Published: (2022-01-01)

Current and future perspectives on the management of polypharmacy
by: Mariam Molokhia, et al.
Published: (2017-06-01)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
by: Bianca Papotti, et al.
Published: (2021-01-01)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic
by: Dario Cattaneo, et al.
Published: (2023-07-01)

Prevalence and differences in the co-administration of drugs known to interact: an analysis of three distinct and large populations
by: Jon Sánchez-Valle, et al.
Published: (2024-04-01)

Individual Pharmacotherapy Management (IPM)—IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy
by: Ursula Wolf, et al.
Published: (2022-10-01)

Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department
by: Elena-Codruța Dobrică, et al.
Published: (2019-08-01)

Polypharmacy in multimorbid older adults: protocol for a systematic review
by: Caroline Sirois, et al.
Published: (2017-05-01)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
by: Ivan Krečak, et al.
Published: (2023-04-01)

Multidisciplinary review and discussion of Drug Related Problems in polypharmacy patients in an emergency department
by: Iosu Barral, et al.
Published: (2019-08-01)

Polypharmacy and Potential Drug Interactions Causing Neurological Symptoms in Geriatric Patients with Epilepsy
by: Bahar Erbaş
Published: (2022-09-01)

Drug utilization pattern and factors associated with polypharmacy and excessive polypharmacy in geriatric medical out-patients at a rural health training centre in India
by: S Nitya, et al.
Published: (2021-01-01)

Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic
by: Dario Cattaneo, et al.
Published: (2024-01-01)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
by: Hermann M, et al.
Published: (2021-03-01)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
by: Assefa YA, et al.
Published: (2020-01-01)

The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study
by: Elnaz Faramarzi, et al.
Published: (2023-06-01)

Frequency of polypharmacy and drug interactions in inpatients in the emergency department, Southwest of Iran
by: Mobina Tahmasebivand, et al.
Published: (2021-03-01)

Evaluation of Polypharmacy and Drug Interactions in the Treatment of Patients with Sepsis
by: Nursel Sürmelioğlu, et al.
Published: (2021-09-01)

Rationale, design, and methodology of the EPIC (Epidemiology of Polypharmacy and Potential Drug-Drug Interactions in Elderly Cardiac Outpatients) study
by: Eda Özlek, et al.
Published: (2019-07-01)

Interplay of multimorbidity and polypharmacy on a community dwelling frail elderly cohort in the peri-urban slums of Delhi, India
by: Meely Panda, et al.
Published: (2020-01-01)

How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention
by: Isabel del Cura-González, et al.
Published: (2022-05-01)

Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study
by: Reham M. Alhumaidi, et al.
Published: (2023-06-01)

Polypharmacy: An Overview
by: Nelisa Paidamwoyo Ganga
Published: (2022-12-01)

Polypharmacy in the elderly
by: Negar Golchin, et al.
Published: (2015-01-01)

Polypharmacy among older adults in Tehran
by: B. Ahmadi, et al.
Published: (2006-08-01)

Polypharmacy and Drug Use Pattern among Indonesian Elderly Patients Visiting Emergency Unit
by: Czeresna Heriawan Soejono, et al.
Published: (2021-03-01)

The (Mis)use of Psychotropic Drugs and Addiction to Anxiolytics among Older Adults Living at Home or in Retirement Homes: Implications for Quality of Life
by: Mirjana Kralj, et al.
Published: (2023-11-01)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
by: Marwan Sheikh-Taha, et al.
Published: (2021-04-01)

Polypharmacy in Osteoporosis Patients
by: Yavuz Ali Karahan, et al.
Published: (2015-04-01)

Polypharmacy and potential inappropriate drug use in the elderly admitted to the general internal medicine outpatient clinic
by: Celaleddin Demircan, et al.
Published: (2021-03-01)

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis
by: Tatsunori Hanai, et al.
Published: (2023-03-01)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
by: Yong Zhao, et al.
Published: (2023-07-01)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
by: Paula Bachmann, et al.
Published: (2022-03-01)

SREBPs as the potential target for solving the polypharmacy dilemma
by: Xue Wang, et al.
Published: (2024-01-01)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
by: Agnieszka Kotalczyk, et al.
Published: (2022-03-01)